Group to Support Providers Through Innovative Digital
Health Solutions as Telemed Patients Show Increases up to 175%
During the Pandemic
PALO ALTO, CA - July 28, 2020 — StartX, a non-profit startup community of more than 1600 Stanford faculty and alumni founders, announces the launch of its StartX Med Alliance of Remote and Telehealth (SMART) Initiative and the mobilization of its digital health medical companies to support healthcare providers in their delivery oftelehealth, remote monitoring, remote diagnostics, and virtual care services. The consortium will collaborate on partnerships with healthcare providers and government agencies to help them respond to the massive shifts in patient care delivery caused by the COVID-19 pandemic.
The SMART Initiative is part of the StartX Med COVID-19 Task Force and provides a range of innovative solutions that equip frontline providers in their day-to-day care delivery, helping to minimize health risks to providers and patients in this new COVID-19 environment. Examples of innovation include remote patient monitoring of respiratory and cardiovascular diseases, software enabling clinics to offer high volume drive-by COVID-19 testing, remote stem cell and blood sampling for point-of-care use, telehealth and virtual care platforms for physician practices and senior care providers, and telemedicine-enabled mobile retinal scanners that allow nurses and medical assistants to detect eye disease rapidly.
The consortium collaborates with healthcare providers serving high-risk and vulnerable patients in U.S. regions that have been the hardest hit by COVID-19. As such, the StartX companies are offering their solutions and support to healthcare providers that receive funding from the Federal Communications Commission COVID-19 Telehealth Program. The consortium is engaging hospitals, senior care providers, community health centers, local health departments, and providers in other settings to support their telehealth, remote monitoring, and remote diagnostics initiatives.
“Digital health has seen a dramatic shift in recent months with the public recognizing its critical role and ease of use during the pandemic,” stated Sentinel Chief Medical Officer, Jorge Sanchez, MD. “Health systems are adopting telemedicine and remote diagnostics for quarantined patients at an incredible rate and seeing the advantages in relieving overstressed physicians. With up to 175% increase in telehealth patients reported in recent months, it is becoming clear that this is the new doctor on call.”
“Seniors and their care teams have been hit extremely hard by COVID-19, especiallyin nursing homes and other long-term care facilities. Many providers quickly responded by adopting telehealth and have been able to reduce the risk of disease transmission while ensuring patients receive undisrupted access to treatments and their clinical teams,” stated Kijoon Lee, CEO of Teleon Health. “Virtual care and telehealth have become critical in protecting healthcare workers and enabling seniors to safely access the care they need, whether at home or in care facilities. We’re seeing a major shift in the senior care model that will improve the quality andefficiency of care far beyond this pandemic.”
Current StartX Med Alliance of Remote and Telehealth Companies include:
Aromyx - DawnLight - Eko - Enya - Gauss Surgical - Kangaroo Health - Luma Health - Nanowear - Remedly - Sandstone DX - Sentinel Health - Spect - Spry Health - Synova Life Sciences - Teleon Health - Wellsheet
“The magnitude of the pandemic has taken the world by surprise and we need to look to the startup community where leading-edge innovation happens,” stated Joseph Huang, StartX CEO. “This is especially prevalent in the telehealth and remote diagnostics sectors where advancements were already proven and commercially ready to deploy prior to COVID-19. Founders in our community have been collaborating for the last five months on the full spectrum of COVID-care from telemedicine and coordinated supply chain data to therapeutics, testing, and med devices as part of the StartX Med COVID-19 Task Force.”
Founded at the onset of the pandemic, the StartX Med COVID-19 Task Force consists of more than 150 Stanford alumni scientists, physicians, professors, and engineers providing solutions for the Prevention, Diagnostics, and Treatment of COVID-19.
StartX and StartX Med, the medical entrepreneurial vertical of StartX, includes accomplished founders ranging from undergraduates and masters students to postdocs, professors and Stanford alumni being mentored by top Silicon Valley industry leaders. For medical tech founders homegrown at Stanford’s School of Medicine, having intimate access to domain experts and care environments has been fundamental to their success. StartX Med entrepreneurial scientists are changing the world with medical breakthroughs and successful life-saving research trials, including an average of more than six FDA approvals per year. Clinical partners of StartX Med companies encompass more than 250 hospitals, 30,000 carecenters, 50,000 physicians and 65 million annual patient visits. StartX Med founders also have the opportunity to utilize 2,000 square feet of shared wet lab space at the StartX facility, located down the street from Stanford University. StartX continues to be a unique startup community compared to accelerators and incubators and does not take equity in companies for admittance into its programs.